Venkatesh Ramnath

So whether it's a sleep study, you know, for someone with obstructive sleep apnea or difficulty sleeping at night, or it's some ophthalmology technology, or it's some ultrasound machine, it doesn't really matter what it is. Medicare is always trying to minimize costs, which is understandable. They want to make it cost effective, but they are setting the lead. So everyone will follow what they do.

So whether it's a sleep study, you know, for someone with obstructive sleep apnea or difficulty sleeping at night, or it's some ophthalmology technology, or it's some ultrasound machine, it doesn't really matter what it is. Medicare is always trying to minimize costs, which is understandable. They want to make it cost effective, but they are setting the lead. So everyone will follow what they do.

That's kind of the way that our system is sort of set up.

That's kind of the way that our system is sort of set up.

That's kind of the way that our system is sort of set up.

I do want to add something here, and I do want to be careful about the term, because telemedicine and telehealth are not only sort of a catch-all, but they're sort of used interchangeably, right? And just like anything, you have to be specific about the term. So I think what we're talking about on this podcast is telemedicine in terms of a two-way audiovisual technology.

I do want to add something here, and I do want to be careful about the term, because telemedicine and telehealth are not only sort of a catch-all, but they're sort of used interchangeably, right? And just like anything, you have to be specific about the term. So I think what we're talking about on this podcast is telemedicine in terms of a two-way audiovisual technology.

I do want to add something here, and I do want to be careful about the term, because telemedicine and telehealth are not only sort of a catch-all, but they're sort of used interchangeably, right? And just like anything, you have to be specific about the term. So I think what we're talking about on this podcast is telemedicine in terms of a two-way audiovisual technology.

interface where you can have a direct face-to-face consultation or interaction with a practicing practitioner. Usually that's going to be a physician, but it may be a nurse practitioner or other physician extender, we call them. But just to be clear, telemedicine also extends to

interface where you can have a direct face-to-face consultation or interaction with a practicing practitioner. Usually that's going to be a physician, but it may be a nurse practitioner or other physician extender, we call them. But just to be clear, telemedicine also extends to

interface where you can have a direct face-to-face consultation or interaction with a practicing practitioner. Usually that's going to be a physician, but it may be a nurse practitioner or other physician extender, we call them. But just to be clear, telemedicine also extends to

other types of devices like wearables, those things that they're either, you know, trackers that you can wear as your Fitbit or a sleep device, you know, that you can wear around. Those kinds of things are kind of put into the telemedicine bucket and And it's not clear to me, at least, how that is going to change.

other types of devices like wearables, those things that they're either, you know, trackers that you can wear as your Fitbit or a sleep device, you know, that you can wear around. Those kinds of things are kind of put into the telemedicine bucket and And it's not clear to me, at least, how that is going to change.

other types of devices like wearables, those things that they're either, you know, trackers that you can wear as your Fitbit or a sleep device, you know, that you can wear around. Those kinds of things are kind of put into the telemedicine bucket and And it's not clear to me, at least, how that is going to change.

I think April 1st is when the face-to-face coverage from a professional fee standpoint, that is slated to end because they did liberalize it during the COVID pandemic. And it's been extended, I think, another year around that. And that will definitely change the dynamic here. But it's not clear how much of it extends to other types of remote physiologic monitoring services and products.

I think April 1st is when the face-to-face coverage from a professional fee standpoint, that is slated to end because they did liberalize it during the COVID pandemic. And it's been extended, I think, another year around that. And that will definitely change the dynamic here. But it's not clear how much of it extends to other types of remote physiologic monitoring services and products.

I think April 1st is when the face-to-face coverage from a professional fee standpoint, that is slated to end because they did liberalize it during the COVID pandemic. And it's been extended, I think, another year around that. And that will definitely change the dynamic here. But it's not clear how much of it extends to other types of remote physiologic monitoring services and products.

Yeah, it's a tough time, certainly. And coming out of the pandemic, this is not what really anybody expected. But the stresses have been mounting for quite a while, right? Healthcare professionals are seeing and feeling more stress at work, whether it's the demands of the job, meaning that there are fewer resources to spend on a heightened number of patients with increasingly complex diseases.

Yeah, it's a tough time, certainly. And coming out of the pandemic, this is not what really anybody expected. But the stresses have been mounting for quite a while, right? Healthcare professionals are seeing and feeling more stress at work, whether it's the demands of the job, meaning that there are fewer resources to spend on a heightened number of patients with increasingly complex diseases.

Yeah, it's a tough time, certainly. And coming out of the pandemic, this is not what really anybody expected. But the stresses have been mounting for quite a while, right? Healthcare professionals are seeing and feeling more stress at work, whether it's the demands of the job, meaning that there are fewer resources to spend on a heightened number of patients with increasingly complex diseases.